BioSante Pharmaceuticals, Inc. (ANIP)

Last Three Months

23-Aug-24 -- 22-Nov-24

Time Period:

Three Months
|
Year

0 Net Amount

Buy:	0	--
Sell:	0	--

Company Sentiment

Biotechnology

Drugs

Insider Trading Sentiment: Strong Sell

Insider Trading Sentiment: Strong Buy

Sentiment Breakdown by Insider

0

(3)

0

(2)

1

(1)

37

0

0

+1

0

+2

0

+3

Two Year Chart

23-Nov-22 -- 22-Nov-24

Price ($)

Two Year Stock Price Chart

Sentiment

Buy & Sell Volume ($)

Two Year Insider Trading Volume Chart

Recent Insider Trades

Last Transaction		Last Three Months
SEC Filing	Transaction	Insider	Sentiment	Company	Holdings Change	Buy Amount	Sell Amount	Buy Price Range	Sell Price Range
10-Sep-24 4:44 PM View:	08-Sep-24 Payment of Exercise ($220.62K)	Lalwani Nikhil PRESIDENT & CEO Director		BioSante Pharmaceuticals, Inc. - ANIP	(1%) 377.5K to 373.86K	0	0	--	--	Show Txns Hide Txns

18-Nov-24 4:03 PM View:	15-Nov-24 Private Sale ($375.05K)	Mutz Christopher HEAD OF RARE DISEASE		BioSante Pharmaceuticals, Inc. - ANIP	(8%) 83.28K to 76.78K	0	0	--	--	Show Txns Hide Txns

14-Nov-24 4:16 PM View:	13-Nov-24 Private Sale (Planned) ($15.34K)	Cook Meredith SR. VP, GENERAL COUNSEL & SEC.		BioSante Pharmaceuticals, Inc. - ANIP	(1%) 56.99K to 56.24K	0	0	--	--	Show Txns Hide Txns

13-Sep-24 4:23 PM View:	12-Sep-24 Payment of Exercise ($83.44K)	Davis Krista SVP, CHIEF HR OFFICER		BioSante Pharmaceuticals, Inc. - ANIP	(3%) 51.55K to 50.06K	0	0	--	--	Show Txns Hide Txns

18-Nov-24 4:05 PM View:	15-Nov-24 Payment of Exercise ($49.05K)	Rowland Thomas Andrew SVP, HEAD - ESTABLISHED BRANDS		BioSante Pharmaceuticals, Inc. - ANIP	(3%) 34.04K to 33.17K	0	0	--	--	Show Txns Hide Txns